• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分子杂交方法获得的 1-(3',4',5'-三甲氧基苯基)-3-(2'-烷氧基羰基吲哚基)-2-丙烯-1-酮衍生物的设计、合成、体外增殖活性和诱导凋亡研究。

Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.

机构信息

a Department of Chemical and Pharmaceutical Sciences , University of Ferrara , Ferrara , Italy.

b Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research , National Cancer Institute, National Institutes of Health , Frederick , MD , USA.

出版信息

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1225-1238. doi: 10.1080/14756366.2018.1493473.

DOI:10.1080/14756366.2018.1493473
PMID:30141353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6116705/
Abstract

Inhibition of microtubule function using tubulin targeting agents has received growing attention in the last several decades. The indole scaffold has been recognized as an important scaffold in the design of novel compounds acting as antimitotic agents. Indole-based chalcones, in which one of the aryl rings was replaced by an indole, have been explored in the last few years for their anticancer potential in different cancer cell lines. Eighteen novel (3',4',5'-trimethoxyphenyl)-indolyl-propenone derivatives with general structure 9 were synthesized and evaluated for their antiproliferative activity against a panel of four different human cancer cell lines. The highest IC values were obtained against the human promyelocytic leukemia HL-60 cell line. This series of chalcone derivatives was characterized by the presence of a 2-alkoxycarbonyl indole ring as the second aryl system attached at the carbonyl of the 3-position of the 1-(3',4',5'-trimethoxyphenyl)-2-propen-1-one framework. The structure-activity relationship (SAR) of the indole-based chalcone derivatives was investigated by varying the position of the methoxy group, by the introduction of different substituents (hydrogen, methyl, ethyl or benzyl) at the N-1 position and by the activity differences between methoxycarbonyl and ethoxycarbonyl moieties at the 2-position of the indole nucleus. The antiproliferative activity data of the novel synthesized compounds revealed that generally N-substituted indole analogues exhibited considerably reduced potency as compared with their parent N-unsubstituted counterparts, demonstrating that the presence of a hydrogen on the indole nitrogen plays a decisive role in increasing antiproliferative activity. The results also revealed that the position of the methoxy group on the indole ring is a critical determinant of biological activity. Among the synthesized derivatives, compound 9e, containing the 2-methoxycarbonyl-6-methoxy-N-1H-indole moiety exhibited the highest antiproliferative activity, with IC values of 0.37, 0.16 and 0.17 μM against HeLa, HT29 and MCF-7 cancer cell lines, respectively, and with considerably lower activity against HL-60 cells (IC: 18 μM). This derivative also displayed cytotoxic properties (IC values ∼1 μM) in the human myeloid leukemia U-937 cell line overexpressing human Bcl-2 (U-937/Bcl-2) via cell cycle progression arrest at the G-M phase and induction of apoptosis. The results obtained also demonstrated that the antiproliferative activity of this molecule is related to inhibition of tubulin polymerisation. The presence of a methoxy group at the C5- or C6-position of the indole nucleus, as well as the absence of substituents at the N-1-indole position, contributed to the optimal activity of the indole-propenone-3',4',5'-trimethoxyphenyl scaffold.

摘要

几十年来,使用微管靶向剂抑制微管功能受到了越来越多的关注。吲哚骨架已被公认为设计作为抗有丝分裂剂的新型化合物的重要骨架。在过去的几年中,基于吲哚的查尔酮,其中一个芳环被吲哚取代,因其在不同癌细胞系中的抗癌潜力而被探索。合成了十八种新型(3',4',5'-三甲氧基苯基)-吲哚基丙烯酮衍生物,其通用结构为 9,并对其针对四种不同人类癌细胞系的抗增殖活性进行了评估。对人早幼粒细胞白血病 HL-60 细胞系的最高 IC 值。该系列查尔酮衍生物的特征在于存在 2-烷氧羰基吲哚环作为第二个芳基系统,连接在 1-(3',4',5'-三甲氧基苯基)-2-丙烯-1-酮框架的 3-位的羰基上。通过改变甲氧基的位置,通过在 N-1 位引入不同的取代基(氢,甲基,乙基或苄基)以及吲哚核 2-位甲氧基羰基和乙氧基羰基部分之间的活性差异,研究了基于吲哚的查尔酮衍生物的构效关系(SAR)。新型合成化合物的抗增殖活性数据表明,一般来说,与母体未取代的化合物相比,N-取代的吲哚类似物的效力明显降低,这表明吲哚氮上存在氢在增加抗增殖活性方面起着决定性作用。结果还表明,吲哚环上甲氧基的位置是决定生物活性的关键因素。在所合成的衍生物中,含有 2-甲氧羰基-6-甲氧基-N-1H-吲哚部分的化合物 9e 对 HeLa、HT29 和 MCF-7 癌细胞系的抗增殖活性最高,IC 值分别为 0.37、0.16 和 0.17 μM,对 HL-60 细胞的活性明显降低(IC:18 μM)。该衍生物在人髓样白血病 U-937 细胞系中也表现出细胞毒性特性(IC 值约为 1 μM),通过细胞周期停滞在 G-M 期和诱导细胞凋亡来过度表达人 Bcl-2(U-937/Bcl-2)。还证明了该分子的抗增殖活性与微管聚合的抑制有关。吲哚核的 C5-或 C6-位上存在甲氧基以及 N-1-吲哚位上没有取代基,有助于优化吲哚-丙烯酮-3',4',5'-三甲氧基苯基支架的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/a2f717d117dd/IENZ_A_1493473_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/6cc1d4d6b1e8/IENZ_A_1493473_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/973dc30c0517/IENZ_A_1493473_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/83b811960d16/IENZ_A_1493473_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/5c2cd8583c22/IENZ_A_1493473_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/b9a6eaf48f0b/IENZ_A_1493473_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/854efebfea99/IENZ_A_1493473_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/a2f717d117dd/IENZ_A_1493473_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/6cc1d4d6b1e8/IENZ_A_1493473_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/973dc30c0517/IENZ_A_1493473_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/83b811960d16/IENZ_A_1493473_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/5c2cd8583c22/IENZ_A_1493473_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/b9a6eaf48f0b/IENZ_A_1493473_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/854efebfea99/IENZ_A_1493473_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b35/6116705/a2f717d117dd/IENZ_A_1493473_SCH0001_B.jpg

相似文献

1
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.通过分子杂交方法获得的 1-(3',4',5'-三甲氧基苯基)-3-(2'-烷氧基羰基吲哚基)-2-丙烯-1-酮衍生物的设计、合成、体外增殖活性和诱导凋亡研究。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1225-1238. doi: 10.1080/14756366.2018.1493473.
2
Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells.α-溴丙烯酰氨基吲哚基吡啶基丙烯酮作为人白血病细胞中有效的凋亡诱导剂的合成及生物学评价
J Enzyme Inhib Med Chem. 2018 Dec;33(1):727-742. doi: 10.1080/14756366.2018.1450749.
3
The synthetic flavanone 6-methoxy-2-(naphthalen-1-yl)chroman-4-one induces apoptosis and activation of the MAPK pathway in human U-937 leukaemia cells.合成黄酮 6-甲氧基-2-(萘-1-基)色满-4-酮诱导人 U-937 白血病细胞凋亡和 MAPK 通路的激活。
Bioorg Chem. 2020 Jan;94:103450. doi: 10.1016/j.bioorg.2019.103450. Epub 2019 Nov 21.
4
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.2-烷氧羰基-3-芳氨基-5-取代噻吩类新型抗微管蛋白剂:设计、合成、细胞生长及微管蛋白聚合抑制作用
Eur J Med Chem. 2018 Jan 1;143:683-698. doi: 10.1016/j.ejmech.2017.11.096.
5
Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.一系列含吲哚基团的吡喃查尔酮衍生物作为新型抗微管蛋白剂的设计、合成及生物学评价
Bioorg Med Chem. 2014 Apr 1;22(7):2060-79. doi: 10.1016/j.bmc.2014.02.028. Epub 2014 Mar 1.
6
Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization.设计、合成及生物评价 2-烷氧基羰基-3-苯胺基吲哚类化合物作为新型强效微管蛋白聚合抑制剂。
Bioorg Chem. 2020 Apr;97:103665. doi: 10.1016/j.bioorg.2020.103665. Epub 2020 Feb 18.
7
Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.新型含吗啉和硫代吗啉部分的吲哚-嘧啶杂合体的合成与生物评价。
Eur J Med Chem. 2017 Jul 7;134:110-118. doi: 10.1016/j.ejmech.2017.04.011. Epub 2017 Apr 7.
8
Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study.鉴定新型 3-苯基-1H-吲哚-2-甲酰肼衍生物作为新型强效微管蛋白抑制剂和抗癌剂的构效关系:一项联合计算机模拟、体外和合成研究。
Bioorg Chem. 2021 May;110:104795. doi: 10.1016/j.bioorg.2021.104795. Epub 2021 Mar 4.
9
Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.吲哚三唑缀合物的合成及初步临床评价,作为有效的微管靶向剂,针对 MCF-7 乳腺癌细胞系。
Anticancer Agents Med Chem. 2021;21(8):1047-1055. doi: 10.2174/1871520620666200925102940.
10
Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives.新型吲哚-2-羧酸酯衍生物的设计、合成及抗增殖活性研究。
Eur J Med Chem. 2014 Aug 18;83:409-18. doi: 10.1016/j.ejmech.2014.05.043. Epub 2014 May 15.

引用本文的文献

1
Selective Anticancer Activity and Safety Profile of Chlorochalcones: Impact on Breast Cancer, Blood, and Endothelial Cells.氯代查耳酮的选择性抗癌活性及安全性:对乳腺癌、血液和内皮细胞的影响
Cells. 2025 Aug 21;14(16):1299. doi: 10.3390/cells14161299.
2
Research status of indole-modified natural products.吲哚修饰的天然产物的研究现状
RSC Med Chem. 2023 Oct 17;14(12):2535-2563. doi: 10.1039/d3md00560g. eCollection 2023 Dec 13.
3
Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity.

本文引用的文献

1
A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.一组新型高效的鼻病毒复制小分子抑制剂
J Med Chem. 2017 Jul 13;60(13):5472-5492. doi: 10.1021/acs.jmedchem.7b00175. Epub 2017 Jun 15.
2
Chalcone: A Privileged Structure in Medicinal Chemistry.查尔酮:药物化学中的一种优势结构。
Chem Rev. 2017 Jun 28;117(12):7762-7810. doi: 10.1021/acs.chemrev.7b00020. Epub 2017 May 10.
3
Antiproliferative activity and apoptosis induction by 3',4'-dibenzyloxyflavonol on human leukemia cells.3',4'-二苄氧基黄酮醇对人白血病细胞的抗增殖活性及凋亡诱导作用
苯并三唑取代的 2-苯基喹唑啉类化合物作为抗癌剂:合成、筛选、抗增殖和微管蛋白聚合抑制活性。
Curr Cancer Drug Targets. 2023;23(4):278-292. doi: 10.2174/1568009623666221028121906.
4
A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.综述:合成查耳酮衍生物作为微管蛋白聚合抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):9-38. doi: 10.1080/14756366.2021.1976772.
5
Pyrrolo[2',3':3,4]cyclohepta[1,2-][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types.吡咯并[2',3':3,4]环庚[1,2-][1,2]恶唑,一类新型抗有丝分裂剂,对多种恶性细胞类型具有活性。
J Med Chem. 2020 Oct 22;63(20):12023-12042. doi: 10.1021/acs.jmedchem.0c01315. Epub 2020 Oct 11.
Chem Biol Interact. 2017 Apr 25;268:13-23. doi: 10.1016/j.cbi.2017.02.010. Epub 2017 Feb 22.
4
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth.通过使微管蛋白不稳定来阻断实体瘤的血流:一种靶向肿瘤生长的方法。
J Med Chem. 2016 Oct 13;59(19):8685-8711. doi: 10.1021/acs.jmedchem.6b00463. Epub 2016 Jun 27.
5
Synthesis and biological evaluation of isomeric methoxy substitutions on anti-cancer indolyl-pyridinyl-propenones: Effects on potency and mode of activity.抗癌吲哚基吡啶基丙烯酮异构体甲氧基取代物的合成与生物学评价:对活性和作用方式的影响。
Eur J Med Chem. 2016 Oct 21;122:79-91. doi: 10.1016/j.ejmech.2016.06.016. Epub 2016 Jun 13.
6
Synthesis, Evaluation, and Mechanism Study of Novel Indole-Chalcone Derivatives Exerting Effective Antitumor Activity Through Microtubule Destabilization in Vitro and in Vivo.新型吲哚 - 查尔酮衍生物的合成、评价及作用机制研究:该衍生物通过在体外和体内使微管不稳定发挥有效的抗肿瘤活性
J Med Chem. 2016 Jun 9;59(11):5264-83. doi: 10.1021/acs.jmedchem.6b00021. Epub 2016 May 23.
7
Hematologic malignancies: newer strategies to counter the BCL-2 protein.血液系统恶性肿瘤:对抗BCL-2蛋白的新策略。
J Cancer Res Clin Oncol. 2016 Sep;142(9):2013-22. doi: 10.1007/s00432-016-2144-1. Epub 2016 Apr 4.
8
Discovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.发现3-取代的1H-吲哚-2-羧酸衍生物作为一类新型的半胱氨酰白三烯1(CysLT1)选择性拮抗剂。
ACS Med Chem Lett. 2016 Jan 22;7(3):335-9. doi: 10.1021/acsmedchemlett.5b00482. eCollection 2016 Mar 10.
9
Organocatalytic Synthesis of Fused Bicyclic 2,3-Dihydro-1,3,4-oxadiazoles through an Intramolecular Cascade Cyclization.通过分子内级联环化反应的有机催化合成稠合双环 2,3-二氢-1,3,4-噁二唑
Org Lett. 2015 Dec 4;17(23):5824-7. doi: 10.1021/acs.orglett.5b02997. Epub 2015 Nov 24.
10
Antimitotic drugs in the treatment of cancer.抗有丝分裂药物在癌症治疗中的应用。
Cancer Chemother Pharmacol. 2015 Dec;76(6):1101-12. doi: 10.1007/s00280-015-2903-8. Epub 2015 Nov 12.